Mechanisms of Cyst Expansion in Polycystic Kidney Disease.
作者信息
Schmidt-Ott Kai M
机构信息
Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
出版信息
J Am Soc Nephrol. 2025 Apr 1;36(4):533-535. doi: 10.1681/ASN.0000000643. Epub 2025 Feb 28.
Abstract
摘要
相似文献
1
Mechanisms of Cyst Expansion in Polycystic Kidney Disease.
J Am Soc Nephrol. 2025 Apr 1;36(4):533-535. doi: 10.1681/ASN.0000000643. Epub 2025 Feb 28.
2
Early treatment with 2-deoxy-d-glucose reduces proliferative proteins in the kidney and slows cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (PKD).
Cell Signal. 2024 Nov;123:111351. doi: 10.1016/j.cellsig.2024.111351. Epub 2024 Aug 17.
4
Raising serum uric acid with a uricase inhibitor worsens PKD in rat and mouse models.
Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1004-F1015. doi: 10.1152/ajprenal.00372.2023. Epub 2024 Apr 18.
5
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
6
Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.
Nephrol Dial Transplant. 2017 Jan 1;32(1):144-150. doi: 10.1093/ndt/gfv452.
7
New insights in the pathophysiology and treatment of hypertension in autosomal dominant polycystic kidney disease.
Kidney Int. 2025 Oct;108(4):592-608. doi: 10.1016/j.kint.2025.05.036. Epub 2025 Jul 23.
8
Procalcitonin levels at hospital admission are increased in cyst infection in patients with autosomal dominant polycystic kidney disease.
Acta Clin Belg. 2025 Feb-Apr;80(1-2):25-28. doi: 10.1080/17843286.2025.2518059. Epub 2025 Jun 12.
9
nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease.
Curr Med Imaging. 2024;20:1-9. doi: 10.2174/0115734056272767231130110017.
10
Transcatheter arterial embolization therapy in patients with polycystic kidney disease and liver disease: review from case series.
Clin Exp Nephrol. 2025 Jan;29(1):29-38. doi: 10.1007/s10157-024-02597-1. Epub 2024 Nov 20.
引用本文的文献
1
Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle.
Genes (Basel). 2025 May 27;16(6):642. doi: 10.3390/genes16060642.
本文引用的文献
1
Adamts1 and Cyst Expansion in Polycystic Kidney Disease.
J Am Soc Nephrol. 2025 Apr 1;36(4):559-570. doi: 10.1681/ASN.0000000557. Epub 2024 Nov 8.
2
Role of ADAM and ADAMTS proteases in pathological tissue remodeling.
Cell Death Discov. 2023 Dec 9;9(1):447. doi: 10.1038/s41420-023-01744-z.
3
Mechanisms of Cyst Development in Polycystic Kidney Disease.
Adv Kidney Dis Health. 2023 May;30(3):209-219. doi: 10.1053/j.akdh.2023.03.001.
4
Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis.
Nat Commun. 2022 Oct 30;13(1):6497. doi: 10.1038/s41467-022-34255-z.
5
Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury.
Genome Med. 2022 Sep 9;14(1):103. doi: 10.1186/s13073-022-01108-9.
6
Renal plasticity revealed through reversal of polycystic kidney disease in mice.
Nat Genet. 2021 Dec;53(12):1649-1663. doi: 10.1038/s41588-021-00946-4. Epub 2021 Oct 11.
7
Autophagy in kidney homeostasis and disease.
Nat Rev Nephrol. 2020 Sep;16(9):489-508. doi: 10.1038/s41581-020-0309-2. Epub 2020 Jul 23.
8
Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.
Front Immunol. 2020 Mar 24;11:512. doi: 10.3389/fimmu.2020.00512. eCollection 2020.
9
The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.
Matrix Biol. 2014 Apr;35:34-41. doi: 10.1016/j.matbio.2014.01.005. Epub 2014 Jan 18.
10
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.
Nat Med. 2004 Apr;10(4):363-4. doi: 10.1038/nm1004. Epub 2004 Feb 29.
Zotero 插件